A pharmacokinetic study of the interaction between celecoxib and anticonvulsant drugs [phenytoin, carbamazepine, phenobarbital, primidone, gabapentin, lamotrigine, valproic acid, levetiracetam, tiagabine, topiramate, zonisamide, felbamate, oxcarbazepine] in patients with newly diagnosed glioblastoma multiforme undergoing radiation therapy.

Trial Profile

A pharmacokinetic study of the interaction between celecoxib and anticonvulsant drugs [phenytoin, carbamazepine, phenobarbital, primidone, gabapentin, lamotrigine, valproic acid, levetiracetam, tiagabine, topiramate, zonisamide, felbamate, oxcarbazepine] in patients with newly diagnosed glioblastoma multiforme undergoing radiation therapy.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2015

At a glance

  • Drugs Celecoxib (Primary) ; Carbamazepine; Felbamate; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Primidone; Tiagabine; Topiramate; Valproic acid; Zonisamide
  • Indications Glioblastoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 May 2012 Actual patient number is 35 according to ClinicalTrials.gov.
    • 18 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top